Literature DB >> 2181620

Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy.

A A Masclee1, A C de Best, R de Graaf, O J Cluysenaer, J B Jansen.   

Abstract

The results of ambulatory 24-h esophageal pH monitoring in 67 patients with gastroesophageal reflux symptoms (endoscopic esophagitis, n = 44; normal endoscopy, n = 23) were compared with those of 27 normal subjects without reflux symptoms. Patients with reflux symptoms had significantly increased gastroesophageal reflux compared with normal subjects. Acid reflux time was significantly (p less than 0.001) correlated with the severity of endoscopic esophagitis. Linear discriminant analysis was used to differentiate, for each reflux variable, between patients and controls. When the percentage of overall time at pH below 4 was used as a single determinant of gastroesophageal reflux, the sensitivity and specificity were 81% and 85%, respectively, with 4% as upper limit of normal. Pathologic reflux was found in 61% of the patients with negative endoscopy. Long-term ambulatory pH-metry is of clinical value in detecting pathologic reflux in symptomatic patients with negative endoscopy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181620

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  32 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

Authors:  Philip Katz; Peter J Kahrilas; David A Johnson; Tore Lind; Kerstin Röhss; Barry Traxler; Vincent Hugo; John Dent
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

3.  Erosions or not in GORD? The potential role of oesophageal cell proliferation.

Authors:  C Calabrese; G Cenacchi; D Trerè; A Fabbri; M Derenzini; M Miglioli; G Di Febo
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 4.  Acupuncture for functional gastrointestinal disorders.

Authors:  Toku Takahashi
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

5.  Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux.

Authors:  Robert N Patterson; Brian T Johnston; Joy E S Ardill; Liam G Heaney; Lorcan P A McGarvey
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

6.  Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease.

Authors:  Reginald V N Lord; Steven R DeMeester; Jeffrey H Peters; Jeffrey A Hagen; Dino Elyssnia; Corinne T Sheth; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

Review 7.  [Correct diagnosis for indication in gastroesophageal reflux disease].

Authors:  A H Hölscher; E Bollschweiler; Ch Gutschow; P Malfertheiner
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

8.  Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease.

Authors:  Takeshi Kamiya; Hiroshi Adachi; Makoto Hirako; Michiko Shikano; Eriko Matsuhisa; Tsuneya Wada; Naotaka Ogasawara; Shunsuke Nojiri; Hiromi Kataoka; Makoto Sasaki; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

9.  Effect of Vagus Nerve Integrity on Short and Long-Term Efficacy of Antireflux Surgery.

Authors:  S van Rijn; N F Rinsma; M Y A van Herwaarden-Lindeboom; J Ringers; H G Gooszen; P J J van Rijn; R A Veenendaal; J M Conchillo; N D Bouvy; Adrian A M Masclee
Journal:  Am J Gastroenterol       Date:  2016-03-15       Impact factor: 10.864

10.  Equine model of inducing ulceration in alimentary squamous epithelial mucosa.

Authors:  M J Murray
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.